Pfizer, Transgene, Merck KGaA Enter Collaboration to Develop TG4001 with Avelumab for HPV-Positive Head & Neck Cancer
Tweet Send to a Friend
Transgene announced it has entered a collaboration agreement with the science and technology company Merck KGaA, Darmstadt, Germany, and Pfizer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE